編輯格式
顏色註記方式
APACHE scoce(Acute Physiology and Chronic Health Evaluation)
使用時機:
評分項目(共三大項,採用APACHE II)
| Score | +4 | +3 | +2 | +1 | 0 | +1 | +2 | +3 | +4 |
| Rectal temperature (°C) | ≥41 | 39.0–40.9 | 38.5–38.9 | 36.0–38.4 | 34.0–35.9 | 32.0–33.9 | 30.0–31.9 | ≤29.9 | |
| Mean blood pressure (mmHg) | ≥160 | 130–159 | 110–129 | 70–109 |
50–69 |
≤49 |
|||
| Heart rate (beats/min) | ≥180 | 140–179 | 110–139 | 70–109 |
55–69 | 40–54 | ≤39 | ||
| Respiratory rate (breaths/min) | ≥50 | 35–49 | 25–34 | 12–24 | 10–11 | 6–9 | ≤5 |
||
| Arterial pH | ≥7.70 | 7.60–7.69 | 7.50–7.59 | 7.33–7.49 | 7.25–7.32 | 7.15–7.24 | <7.15 | ||
| Oxygenation・If FiO₂ > 0.5, use A–a DO₂・If FiO₂ ≤ 0.5, use PaO₂ | ≤500 |
350–499 (A–a DO₂) | 200–349 (A–a DO₂) | 350–499 (A–a DO₂), 61–70 (PaO₂) | 200–349 (A–a DO₂), >70 (PaO₂) | <200 (A–a DO₂), 55–60 (PaO₂) | <55 (PaO₂) | ||
| Serum sodium (mEq/L) | ≥180 | 160–179 | 155–159 | 150–154 | 130–149 | 120–129 | 111–119 | ≤110 | |
| Serum potassium (mEq/L) | ≥7.0 | 6.0–6.9 | 5.5–5.9 | 3.5–5.4 | 3.0–3.4 | 2.5–2.9 | <2.5 |
||
| Serum creatinine (mg/dL) | ≥3.5* | 2.0–3.4 | 1.5–1.9 | 0.6–1.4 | <0.6 |
||||
| Hematocrit (%) | ≥60 | 50–59.9 | 46–49.9 | 30–45.9 | 20–29.9 | <20 |
|||
| WBC count (10⁹/L) | ≥40 | 20–39.9 | 15–19.9 | 3.0–14.9 | 1.0–2.9 |
<1.0 |
|||
| Glasgow Coma Scale (GCS) | 分數 = 15 – GCS 得分(例如 GCS 10 → APS 給 5 分) |
| 年齡範圍 | 加分 |
| < 44 | 0 |
| 45–54 | 2 |
| 55–64 | 3 |
| 65–74 | 5 |
| ≥ 75 | 6 |
慢性健康狀況(Chronic Health Score)
須在入院前6個月已存在,且符合以下嚴重度標準:
| 慢性健康狀況 | 是否加分 | 加幾分 |
| 有以上任一慢性疾病,且此次為非選擇性住院或急診手術 | 是 | +5 分 |
| 有以上慢性疾病,但為選擇性手術住院 | 是 | +2 分 |
| 無符合條件的慢性疾病 | 否 | +0 分 |
| APACHE II 總分 | 死亡率(大約值) | 臨床意義 |
| 0–4 | < 4% | 非常輕症,死亡風險極低 |
| 5–9 | 4–10% | 輕度器官功能異常,有可逆性 |
| 10–14 | 10–15% | 中度重症,需持續監測與干預 |
| 15–19 | 15–25% | 有器官衰竭風險,預後需看反應與處置 |
| 20–24 | 25–40% | 高風險族群,常合併多重器官功能障礙 |
| 25–29 | 40–55% | 極高風險,預後差,應考慮目標治療與倫理議題 |
| 30–34 | 55–75% | 非常重症,多數合併敗血症、ARDS、腎衰竭等 |
| ≥35 | >75%,可達 85–90% | 接近極限生理狀態,死亡機率極高 |
Reference